Suvorexant (Belsomra) for Insomnia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2015年 / 57卷 / 1463期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [41] New pharmacological strategies for the management of insomnia : Suvorexant, one receptor antagonists orexin
    Salin-Pascual, Rafael J.
    REVISTA MEXICANA DE NEUROCIENCIA, 2016, 17 (06): : 97 - 105
  • [42] EFFICACY OF SUVOREXANT FOR INSOMNIA DISORDER IN WELL-CONTROLLED RESTLESS LEGS SYNDROME
    Winkelman, John
    Zackon, Jordana
    SLEEP, 2024, 47
  • [43] ADHERENCE IMPROVEMENT EFFECT OF SUVOREXANT WITH POOR ADHERENCE CAUSED BY INSOMNIA UNDER CPAP USAGE
    Gohira, Y.
    JOURNAL OF SLEEP RESEARCH, 2017, 26 : 44 - 45
  • [44] EFFICACY OF SUVOREXANT FOR INSOMNIA DISORDER IN PATIENTS WITH POORLY-CONTROLLED TYPE 2 DIABETES
    Winkelman, John
    Wipper, Benjamin
    Zackon, Jordana
    Hoeppner, Bettina
    SLEEP, 2023, 46 : A176 - A176
  • [45] Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial
    Campbell, Erin J.
    Norman, Amanda
    Bonomo, Yvonne
    Lawrence, Andrew J.
    BRAIN RESEARCH, 2020, 1728
  • [46] Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
    Hrishikesh P. Kale
    Zaina P. Qureshi
    Ruchit Shah
    Rezaul Khandker
    Marc Botteman
    Weilin Meng
    Ruth Benca
    Advances in Therapy, 2021, 38 : 5221 - 5237
  • [47] Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
    Shigetsura, Yuki
    Imai, Satoshi
    Endo, Hiroki
    Shimizu, Yumi
    Ueda, Keita
    Murai, Toshiya
    Itohara, Kotaro
    Nakagawa, Shunsaku
    Yonezawa, Atsushi
    Ikemi, Yasuaki
    Fukatsu, Sachio
    Kitada, Noriaki
    Terada, Tomohiro
    Nakagawa, Takayuki
    Matsubara, Kazuo
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (03) : 52 - 60
  • [48] Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant
    Norman, Jessica L.
    Anderson, Sarah L.
    NATURE AND SCIENCE OF SLEEP, 2016, 8 : 239 - 247
  • [49] Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
    Kale, Hrishikesh P.
    Qureshi, Zaina P.
    Shah, Ruchit
    Khandker, Rezaul
    Botteman, Marc
    Meng, Weilin
    Benca, Ruth
    ADVANCES IN THERAPY, 2021, 38 (10) : 5221 - 5237
  • [50] AROUSABILITY OF INSOMNIA PATIENTS IS NOT IMPACTED BY THE OREXIN ANTAGONIST SUVOREXANT (10 MG AND 20 MG)
    Drake, Christopher L.
    Cuamatzi-Castelan, Andrea S.
    Kalmbach, David A.
    Cheng, Philip
    Roth, Thomas
    Singh, Meeta
    Tran, Michelle K.
    Tonnu, Christine V.
    Atkinson, Rachel
    Fellman-Couture, Cynthia
    SLEEP, 2019, 42
12345